Clinical Trials in Nashville

Showing 6341-6360 of 20,298 trials

A Study of Rebastinib (DCC-2036) in Combination With Carboplatin in Patients With Advanced or Metastatic Solid Tumors

NCT03717415

This is an open-label Phase 1b/2 multicenter study of rebastinib (DCC-2036) in combination with carboplatin designed to evaluate the safety, tolerability, and pharmacokinetics (PK) in participants with advanced or metastatic solid tumors.

Locally Advanced or Metastatic Solid Tumor

Deciphera Pharmaceuticals, LLC70 participantsStarted Jan 2019

San Francisco, California, United States • Santa Monica, California, United States • Chicago, Illinois, United States +6 more locations

TERMINATEDNA< 1 mile

InterStim Micro Post Market Clinical Follow-up Study (ELITE)

NCT04506866

Post-market clinical follow-up for continued assessment of safety and performance to confirm long-term outcomes of the InterStim Micro System for sacral neuromodulation.

Overactive BladderFecal IncontinenceNon-obstructive Urinary Retention

MedtronicNeuro148 participantsStarted Aug 2020

Jacksonville, Florida, United States • Tampa, Florida, United States • Jeffersonville, Indiana, United States +21 more locations

A Study of Rebastinib (DCC-2036) in Combination With Carboplatin in Patients With Advanced or Metastatic Solid Tumors

InterStim Micro Post Market Clinical Follow-up Study (ELITE)

Find Trials by Condition in Nashville

Study to Assess Safety, Tolerability and Clinical Activity of BGB-290 in Combination With Temozolomide (TMZ) in Participants With Locally Advanced or Metastatic Solid Tumors

A Trial of Belzutifan (PT2977, MK-6482) in Combination With Cabozantinib in Patients With Clear Cell Renal Cell Carcinoma (ccRCC) (MK-6482-003)

Chimney EndoVascular Aneurysm Sealing Of New Expanded Indication

A Phase 2 Study of MP-376 to Prevent Acute Exacerbations in Chronic Obstructive Pulmonary Disease (COPD) Patients

BXQ-350 in Newly Diagnosed Metastatic Colorectal Carcinoma

Extension Study of Pimavanserin in Adult Subjects With Neuropsychiatric Symptoms Related to Neurodegenerative Disease

VTX958 Versus Placebo for the Treatment of Active Psoriatic Arthritis (Tranquility-PsA)

A Study to Evaluate the Safety and Efficacy of AZD5718 in Participants With Proteinuric Chronic Kidney Disease

Long-Term Safety Follow-up Study of Cysteamine Bitartrate Delayed-release Capsules (RP103)

Oral AMXT 1501 Dicaprate in Combination With IV DFMO

A Study Evaluating Potential Disease-Mediated Drug-Drug Interaction in Adult Participants With Active Eosinophilic Esophagitis Receiving Cendakimab

Safety/Effectiveness Study of Cysteamine Bitartrate Delayed-release Capsules (RP103) in Cysteamine Treatment Naive Patients With Cystinosis

Open-Label, Dose-Escalating Study Assessing Safety, Tolerability, Efficacy, of RP103 in Mitochondrial Disease

Genetic Analysis of Attention Deficit Hyperactivity Disorder (ADHD)

Investigation of Safety, Tolerability and Maximum Tolerated Dose (MTD) of BI 2536 in Patients With Recurrent Advanced Aggressive Non-Hodgkin's Lymphoma (NHL)

Study of SIRPant-M in Participants With Relapsed or Refractory Non-Hodgkin's Lymphoma

Oral ONC201 in Adult Recurrent Glioblastoma

Global Fenestrated Anaconda Clinical STudy